{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:33:35Z","timestamp":1771101215396,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Serum pepsinogen assay (sPGA) combining concentration of pepsinogen I (PG I), and the ratio of PG I\/II is the noninvasive biomarker for predicting chronic atrophic gastritis (CAG) and neoplasms reflecting mucosal secretory status. Although various cut-off values have been suggested, PG I \u226470\u200ang\/mL and PG I\/II \u22643 have been widely accepted. However, previous studies for diagnostic test accuracy presented only pooled outcomes, which cannot discriminate the diagnostic validity of sPGA with cut-off of PG I \u226470\u200ang\/mL and PG I\/II \u22643.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will search the core databases [MEDLINE (through PubMed), the Cochrane Library, and Embase] from their inception to December 2018 by 2 independent evaluators. The P.I.C.O. is as follows; Patients: who have histologically proven CAG or gastric neoplasms, Intervention: sPGA with cut-off of PG I \u226470\u200ang\/mL and\/or PG I\/II \u22643, Comparison: none, Outcome: diagnostic performance indices of sPGA for CAG and gastric neoplasms (sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios) (if, true\/false positive, true\/false negative values are presented, diagnostic performance indices will be calculated). All types of study design with full text will be sought and included. The risk of bias will be assessed using the QUADAS-2 tool. Descriptive data synthesis is planned and quantitative synthesis (bivariate and HSROC model) will be used if the included studies are sufficiently homogenous. Publication bias will be assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results will provide clinical evidence for diagnostic validity of sPGA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will provide evidence of sPGA for predicting CAG and gastric neoplasms.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014240","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14240","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms"],"prefix":"10.1097","volume":"98","author":[{"given":"Chang Seok","family":"Bang","sequence":"first","affiliation":[{"name":"Department of Internal Medicine"},{"name":"Institute of New Frontier Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Jun","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of New Frontier Research"},{"name":"Department of Anesthesiology and Pain Medicine, Hallym University College of Medicine, Chuncheon, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwang Ho","family":"Baik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230914","first-page":"3554","article-title":"A human model of gastric carcinogenesis","volume":"48","author":"Correa","year":"1988","journal-title":"Cancer Res"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","article-title":"Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands","volume":"134","author":"de Vries","year":"2008","journal-title":"Gastroenterology"},{"key":"R4-20230914","first-page":"92","article-title":"Overviewof current concepts in gastric intestinal metaplasia and gastric cancer","volume":"14","author":"Jencks","year":"2018","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1319.e7","DOI":"10.1053\/j.gastro.2017.01.029","article-title":"Effectiveness of the Korean National Cancer Screening program in reducing gastric cancer mortality","volume":"152","author":"Jun","year":"2017","journal-title":"Gastroenterology"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","article-title":"Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer","volume":"20","author":"Park","year":"2015","journal-title":"J Cancer Prev"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/1055-9965.EPI-07-2762","article-title":"Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males","volume":"17","author":"Yanaoka","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/0969141041732184","article-title":"Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening","volume":"11","author":"Dinis-Ribeiro","year":"2004","journal-title":"J Med Screen"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"e0142080","DOI":"10.1371\/journal.pone.0142080","article-title":"Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"e109783","DOI":"10.1371\/journal.pone.0109783","article-title":"Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis","volume":"9","author":"Terasawa","year":"2014","journal-title":"PLoS One"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.14248","article-title":"Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis","volume":"46","author":"Zagari","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.21873\/anticanres.11083","article-title":"A panel of serum biomarkers (GastroPanel(\u00ae) in non-invasive diagnosis of atrophic gastritis. systematic review and meta-analysis","volume":"36","author":"Syrj\u00e4nen","year":"2016","journal-title":"Anticancer Res"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat Med"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1536867X0900900203","article-title":"Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression","volume":"9","author":"Harbord","year":"2009","journal-title":"STATA J"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1593\/neo.03505","article-title":"Validity of serum pepsinogen I\/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma","volume":"6","author":"Dinis-Ribeiro","year":"2004","journal-title":"Neoplasia"},{"key":"R20-20230914","article-title":"Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm","author":"Cha","year":"2018","journal-title":"Korean J Intern Med"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3904\/kjim.2016.166","article-title":"Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:29:49Z","timestamp":1694716189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00060"}},"subtitle":["Protocol for a systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014240","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}